Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 426 to 450

  • AusPAR: Lacosamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Lacosamide

  • AusPAR: Fremanezumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Fremanezumab

  • AusPAR: Siponimod

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Siponimod

  • AusPAR: Alirocumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Alirocumab (rch)

  • AusPAR: Polatuzumab vedotin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Polatuzumab vedotin

  • AusPAR: Artemether

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Artemether

  • AusPAR: Dolutegravir/Lamivudine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dolutegravir/Lamivudine

  • AusPAR: Nitric oxide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nitric oxide

  • AusPAR: Odomzo

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Odomzo

  • AusPAR: Cenegermin (rbe)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cenegermin (rbe)

  • AusPAR: Daptomycin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Daptomycin

  • AusPAR: Stiripentol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Stiripentol

  • AusPAR: Ravulizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ravulizumab

  • AusPAR: Methoxsalen

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Methoxsalen

  • AusPAR: Lifitegrast

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Lifitegrast

  • AusPAR: Mepolizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report Mepolizumab

  • AusPAR: Nivolumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nivolumab

  • AusPAR: Buprenorphine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report Buprenorphine

  • AusPAR: Pegfilgrastim

    Australian public assessment report (AusPar)
    Australian Public Assessment Report Pegfilgrastim

  • AusPAR: Nonacog beta pegol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report Nonacog beta pegol

  • AusPAR: Icatibant (as acetate)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Icatibant (as acetate)